Profiel
Sae-Ho Chong currently works at Elevar Therapeutics, Inc., as Chief Executive Officer & Director from 2022.
Actieve functies van Sae-Ho Chong
Bedrijven | Functie | Begin |
---|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Algemeen Directeur | 01-07-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |